Skyscape Web Viewer : Fischbach's Manual of Laboratory and Diagnostic Tests : Main Index

View All
Poikilocytes
Point-of-care testing (POCT) Diagnostic Testing Diagnostic Testing and the Healthcare Delivery System Overview of Laboratory and Diagnostic Testing Testing Environments Test Results
Polychromatophilia
Polycythemia Blood Studies: Hematology and Coagulation Hematocrit (Hct); Packed Cell Volume (PCV) Hemoglobin (Hb) Tests for Red Blood Cells
Polyhydramnios Amniotic Fluid Index (AFI) Amniotic Fluid Studies Amniotic Fluid Total Volume Prenatal Diagnosis and Tests of Fetal Well-Being
Polymerase chain reaction (PCR)
Polymicrobic disease Diagnosis of Bacterial Disease Diagnosis of Microbial Disease Microbiologic Studies Studies of the Susceptibility of Bacteria to Antimicrobial Agents
Polymorphonuclear leukocytes Basic Blood Test Blood Studies: Hematology and Coagulation Complete Blood Count (CBC)/Hemogram Tests of White Blood Cells White Blood Cell (WBC) Count (Leukocyte Count)
Polymorphonuclear neutrophils (PMNs, Polys)
Polymyositis, antibodies test for Antibodies to Extractable Nuclear Antigens (ENAs) Enzyme-Linked Immunosorbent Assay Screening for Specific Systemic Rheumatic Disease (SRD)
Polysomnography (PSG) Classification of Tests-Sleep Studies Polysomnography (PSG) Polysomnography Study in a Laboratory Environment Sleepiness Test Sleep Studies Special Diagnostic Studies Types and Indications of Tests
Polyuria Routine Urinalysis (Ua) and Related Tests Urine Studies Urine Volume
Population genetics Bibliography-Cytologic, Histologic, and Genetic Studies Cytogenetics Cytologic, Histologic, and Genetic Studies Newborn Screening for Congenital Disorders Pharmacogenomics Population Genetics Special Types of Genetic Studies
Porphobilinogens, quantitative (24-hour) and random, in urine drug effects on Urine Potassium (K), Quantitative (24-Hour) and Random
Porphyria cutanea tarda Timed Urine Tests Urine Potassium (K), Quantitative (24-Hour) and Random Urine Studies
Porphyria tests Tests for Porphyria Urine Potassium (K), Quantitative (24-Hour) and Random
Porphyrins; Fractionation of Erythrocytes and of Plasma
Porphyrins; Fractionation of Erythrocytes and of Plasma, erythropoietic
Porphyrins; Fractionation of Erythrocytes and of Plasma, quantitative (24-hour) and random, in urine Specimen Values Urine Potassium (K), Quantitative (24-Hour) and Random
Portable x-ray machine Chest X-Ray Mammography (Breast X-Ray) Plain (Conventional) X-Rays/Radiography X-Ray and Computed Tomography (CT) Studies
Positioning for procedures Administration of Drugs and Solutions Diagnostic Testing Intratest Phase: Elements of Safe, Effective, Informed Care Management of Environment Positioning for Procedures Presence of Family or Significant Others
Positive predictive value Clinical Value of a Test Diagnostic Testing Grading Guidelines for Scientific Evidence Overview of Laboratory and Diagnostic Testing
Positive-sense RNA virus Hepatitis Tests Immunodiagnostic Studies Viral Tests
Positron emission tomography (PET) brain indications for Overview of Positron Emission Tomography (Pet) Imaging Studies procedure in reference values
Postmortem services Communication Diagnostic Testing Elements of Safe, Effective, Informed Care Throughout the Testing Process The Healthcare Provider's Role in Laboratory and Diagnostic Testing
Posttest Phase: Elements of Safe, Effective, Informed Care
Posttest phase
Potassium, quantitative (24-hour) and random in urine drug effects on Urine Potassium (K), Quantitative (24-Hour) and Random
Potassium, serum
Potassium, stool